Enterprise Value
6.278M
Cash
122.1M
Avg Qtr Burn
-25.09M
Short % of Float
4.03%
Insider Ownership
2.27%
Institutional Own.
62.61%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Fosgonimeton (ATH-1017) Details Alzheimer's disease | Phase 2/3 Data readout | |
Fosgonimeton (ATH-1017) Details Parkinson's disease, Dementia | Phase 2 Update | |
ATH-1105 Details Amyotrophic lateral sclerosis | Phase 1 Data readout |